- In November 2023, BD introduced the PIVO Pro, a groundbreaking needle-free blood collection device. It is the first to integrate seamlessly with both long-term and integrated peripheral IV catheters, including the Nexiva system, which now features the FDA-approved NearPort IV Access
- In October 2023, B. Braun Medical Inc. launched the Introcan Safety 2 IV Catheter, incorporating Multi-Access Blood Control to enhance passive needlestick prevention. The design is aimed at reducing clinicians' exposure to blood, minimizing the risk of bloodborne pathogen transmission during intravenous procedures
- In June 2023, Teleflex Incorporated secured two group purchasing agreements with Premier, Inc., enabling Premier members to access exclusive pricing and terms on Teleflex’s Central Venous and Arterial Vascular Access products
- In July 2022, B. Braun Medical Inc. unveiled its new Introcan Safety 2 IV Catheter featuring one-time blood control. This innovation is designed to improve IV access safety for clinicians by reducing the risk of needlestick injuries and blood exposure
- In May 2022, Access Vascular, Inc. (AVI) received FDA 510(k) clearance for its HydroPICC Dual-Lumen catheter. Built with the same proprietary hydrophilic biomaterial as AVI’s single-lumen HydroPICC and HydroMID® catheters, it demonstrated significant reductions in complications such as occlusions, Deep Vein Thrombosis, phlebitis, and catheter replacements in recent studies
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Intravenous Catheters, Intravenous Infusion Pumps, and Intravenous Needles), End User (Hospitals and Clinics, Ambulatory Surgery Centers, Dialysis Centers, Home Care, and Others), Application (Medication Administration, Administration of Fluid and Nutrition, Transfusion of Blood Products, and Diagnostic Testing) – Industry Trends and Forecast to 2032
.
The Global Intravenous Access Devices Market size was valued at USD 7.28 USD Billion in 2024.
The Global Intravenous Access Devices Market is projected to grow at a CAGR of 5.78% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
